Revised SPC: Somatuline (lanreotide) preparations

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
17 December 2019

Abstract

SPC now highlights that there have been post-marketing reports of gallstones resulting in complications, including cholecystitis, cholangitis, and pancreatitis, requiring cholecystectomy. If complications of cholelithiasis are suspected, discontinue lanreotide.